Skin Laxity
Conditions
Keywords
Ulthera® System, Ultherapy™ Treatment, Ulthera, Inc.
Brief summary
The purpose of this study is to evaluate the Ulthera® System for obtaining lift and tightening of the cheek tissue, reduction of jowling, and improving jawline definition and/or submental skin laxity when increased density treatment is applied.
Detailed description
All enrolled study subjects will receive one full face and neck Ultherapy™ treatment. Pre- and post-treatment photos will be taken. Subjects will be required to return for follow-up visits at 60 days, 90 days, 180 days and 1 year following treatment.
Interventions
Focused ultrasound energy delivered below the surface of the skin.
Sponsors
Study design
Eligibility
Inclusion criteria
* Male or female, aged 30 to 65 years * Subject in good health * Desires lift and tightening of cheek tissue, reduction of jowling, improvement of jawline definition and/or submental skin laxity * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the followup period * Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study
Exclusion criteria
* Presence of an active systemic or local skin disease that may affect wound healing * Severe solar elastosis * Excessive subcutaneous fat on the cheeks * Excessive skin laxity on the lower face and neck * Significant scarring in areas to be treated * Significant open facial wounds or lesions * Severe or cystic acne on the face * Presence of a metal stent or implant in the facial area to be treated, a pacemaker, or cochlear implants
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in Overall Lifting and Tightening of Skin | Baseline to 90 days post treatment | Improvement in overall lifting and tightening of skin was completed by three masked assessors, completing a qualitative assessment of pre- and post-treatment photographs. Masked photo pairs of pre/post treatment photos of each treated subject were provided to each assessor. Each photo pair was consistent in lighting, position, focus. The visit interval of each photo was NOT marked. Each assessor's review was completed independently, with no input from others, assessing the photos for improvement. If improvement was seen, the blinded assessor was to choose the post-treatment photo. Categories of assessment included Improved, No Change, or Incorrect post-treatment photo chosen. The majority assessment among the 3 blinded assessors for each subject was reported. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | Baseline to 60 days, 90 days, 180 days and 1 year post-treatment | Improvement was assessed based on Global Aesthetic Improvement Scale (GAIS) scores. The GAIS was completed based on a live assessment of the subject and a photographic assessment comparing post-treatment photos to baseline photos. The PGAIS was completed by a clinician assessor; SGAIS was completed by the study subject. The GAIS is a 5-point scale (1-5) describing an overall assessment as follows: 1. \- Very Much Improved 2. \- Much Improved 3. \- Improved 4. \- No Change 5. \- Worse |
| Subjects' Assessment of Pain | During Ulthera treatment | Subjects' sensory response to the Ulthera treatment exposures were recorded for each anatomical region treated using a validated Numeric Rating Scale (0-10), with 1 representing no pain and 10 representing the worst pain possible. Subjects rated pain for each transducer, in each treatment region. For statistical analyses, NRS scores were averaged for each transducer depth. |
| Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Baseline to 90 days, 180 days and 1 year post-treatment | Subject satisfaction was determined by scores on a patient satisfaction questionnaire (PSQ) completed at 90 days, 180 days and 1 year post-treatment. Subjects indicated how satisfied they were with their study treatment, i.e., Very Satisfied, Satisfied, Dissatisfied, Very Dissatisfied. Pre-treatment and post-treatment photographs were available for viewing at each follow-up visit interval. Subjects also had a mirror available for real time assessment, comparing their image in the mirror with pre-treatment and post-treatment photos. |
Countries
United States
Participant flow
Recruitment details
Thirty-five (35) subjects were enrolled, 3 were deemed screen failures. Thirty-two (32) received study treatment. The first subject was treated on August 3, 2011 and the last subject was treated on 11/28/2011. The last patient follow-up for the trial was 11/21/2012.
Participants by arm
| Arm | Count |
|---|---|
| Ultherapy Treatment Study subjects received a full face Ultherapy treatment delivering approximately 500 treatment lines at two treatment depths, i.e., 4.5mm and 3.0mm depth. | 32 |
| Total | 32 |
Withdrawals & dropouts
| Period | Reason | FG000 |
|---|---|---|
| Overall Study | Lost to Follow-up | 3 |
| Overall Study | Missed Visit | 2 |
Baseline characteristics
| Characteristic | Ultherapy Treatment |
|---|---|
| Age, Continuous | 55 years |
| Body Mass Index (BMI) | 23.3 kg/m˄2 |
| Fitzpatrick Skin Type I | 1 participants |
| Fitzpatrick Skin Type II | 24 participants |
| Fitzpatrick Skin Type III | 6 participants |
| Fitzpatrick Skin Type IV | 0 participants |
| Fitzpatrick Skin Type V | 1 participants |
| Fitzpatrick Skin Type VI | 0 participants |
| Race/Ethnicity, Customized African American/Black | 1 participants |
| Race/Ethnicity, Customized Caucasian | 30 participants |
| Race/Ethnicity, Customized Hispanic/Latino | 1 participants |
| Region of Enrollment United States | 32 participants |
| Sex: Female, Male Female | 31 Participants |
| Sex: Female, Male Male | 1 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | — / — |
| other Total, other adverse events | 0 / 32 |
| serious Total, serious adverse events | 0 / 32 |
Outcome results
Improvement in Overall Lifting and Tightening of Skin
Improvement in overall lifting and tightening of skin was completed by three masked assessors, completing a qualitative assessment of pre- and post-treatment photographs. Masked photo pairs of pre/post treatment photos of each treated subject were provided to each assessor. Each photo pair was consistent in lighting, position, focus. The visit interval of each photo was NOT marked. Each assessor's review was completed independently, with no input from others, assessing the photos for improvement. If improvement was seen, the blinded assessor was to choose the post-treatment photo. Categories of assessment included Improved, No Change, or Incorrect post-treatment photo chosen. The majority assessment among the 3 blinded assessors for each subject was reported.
Time frame: Baseline to 90 days post treatment
Population: Thirty-five (35) subjects were enrolled; 3 were screen failures. Thirty-two (32) subjects received study treatment. Three (3) subjects were lost-to-follow-up.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Ultherapy Treatment | Improvement in Overall Lifting and Tightening of Skin | 48 percentage of participants improved |
Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.
Improvement was assessed based on Global Aesthetic Improvement Scale (GAIS) scores. The GAIS was completed based on a live assessment of the subject and a photographic assessment comparing post-treatment photos to baseline photos. The PGAIS was completed by a clinician assessor; SGAIS was completed by the study subject. The GAIS is a 5-point scale (1-5) describing an overall assessment as follows: 1. \- Very Much Improved 2. \- Much Improved 3. \- Improved 4. \- No Change 5. \- Worse
Time frame: Baseline to 60 days, 90 days, 180 days and 1 year post-treatment
Population: Three (3) subjects were lost-to-follow-up. Two (2) additional subjects missed the 1 year visit.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Very Much Improved | 7 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Much Improved | 28 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Improved | 59 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - No Change | 7 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Worse | 0 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Very Much Improved | 3 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Much Improved | 10 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Improved | 48 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - No Change | 34 Percentage of Participants |
| Ultherapy Treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Worse | 3 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Improved | 41 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - No Change | 34 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - No Change | 21 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Worse | 0 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Very Much Improved | 3 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Much Improved | 17 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Worse | 3 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Improved | 41 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Very Much Improved | 14 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Much Improved | 24 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Improved | 52 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Much Improved | 17 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Worse | 7 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Very Much Improved | 7 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - No Change | 31 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Very Much Improved | 0 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - No Change | 24 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Much Improved | 10 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Worse | 3 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Improved | 48 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Worse | 0 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Improved | 41 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Very Much Improved | 4 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Worse | 7 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - Much Improved | 7 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Much Improved | 22 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Improved | 70 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - No Change | 0 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | PGAIS - Very Much Improved | 7 Percentage of Participants |
| Treated Subjects GAIS Data - 1 Year Post-treatment | Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment. | SGAIS - No Change | 41 Percentage of Participants |
Subjects' Assessment of Pain
Subjects' sensory response to the Ulthera treatment exposures were recorded for each anatomical region treated using a validated Numeric Rating Scale (0-10), with 1 representing no pain and 10 representing the worst pain possible. Subjects rated pain for each transducer, in each treatment region. For statistical analyses, NRS scores were averaged for each transducer depth.
Time frame: During Ulthera treatment
| Arm | Measure | Group | Value (MEAN) |
|---|---|---|---|
| Ultherapy Treatment | Subjects' Assessment of Pain | 4.5mm Transducer | 4.6 Units on a scale |
| Ultherapy Treatment | Subjects' Assessment of Pain | 3.0mm Transducer | 3.6 Units on a scale |
Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment
Subject satisfaction was determined by scores on a patient satisfaction questionnaire (PSQ) completed at 90 days, 180 days and 1 year post-treatment. Subjects indicated how satisfied they were with their study treatment, i.e., Very Satisfied, Satisfied, Dissatisfied, Very Dissatisfied. Pre-treatment and post-treatment photographs were available for viewing at each follow-up visit interval. Subjects also had a mirror available for real time assessment, comparing their image in the mirror with pre-treatment and post-treatment photos.
Time frame: Baseline to 90 days, 180 days and 1 year post-treatment
Population: Three (3) subjects were lost-to-follow-up. Two (2) subjects missed the 1 year visit.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Ultherapy Treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Very Satisfied | 21 Percentage of Participants |
| Ultherapy Treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Satisfied | 48 Percentage of Participants |
| Ultherapy Treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Dissatisfied | 24 Percentage of Participants |
| Ultherapy Treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Very Dissatisfied | 7 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Very Dissatisfied | 10 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Very Satisfied | 10 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Dissatisfied | 21 Percentage of Participants |
| Treated Subjects GAIS Data - 90 Days Post-treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Satisfied | 59 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Very Dissatisfied | 15 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Satisfied | 41 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Dissatisfied | 37 Percentage of Participants |
| Treated Subjects GAIS Data - 180 Days Post-treatment | Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment | Very Satisfied | 7 Percentage of Participants |